To main content
HOME
OUR COMPANY
OUR COMPANY
CORPORATE GOVERNANCE
PROGRAMS
OUR PEOPLE
INVESTORS
Investors
Shareholder Letters
NEWS
CONTACT US
Pipeline
AdjuTec Pharma portfolio
All products are targeting WHO and CDC critical priority pathogens, with main focus on multidrug-resistant bacterial strains
